BioMaTek ApS: Financial statements 2025
CVR: 38928864
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioMaTek ApS (CVR 38928864) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 305,673 and a net result of DKK 6,138. Equity in the 2025 report amounted to DKK 18,905. The solvency ratio was 3.8%.
- Gross Profit
- DKK 305,673
- Profit/Loss
- DKK 6,138
- Equity
- DKK 18,905
- Total Assets
- DKK 497,937
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 306 t. | 6 t. | 19 t. | 0 |
| 2023 | - | 271 t. | 46 t. | 109 t. | 0 |
| 2022 | - | 101 t. | -118 t. | 62 t. | - |
| 2021 | - | 245 t. | -7 t. | 180 t. | - |
| 2020 | - | 368 t. | 48 t. | 188 t. | - |
Official annual report
How creditworthy is BioMaTek ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioMaTek ApS has published its interim report for the period July 1, 2023 – December 31, 2024.
About BioMaTek ApS
BioMaTek ApS is a Danish company of the type Anpartsselskab based in Bedsted Thy, founded in 2017. The company is in liquidation. The company is registered under the industry Installation af isolering. The management consists of Jacob Morten Schousgaard. The company is owned by K.Y.M. ApS, TVT Group ApS and HN2024 Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 305,673 and a net result of DKK 6,138. Equity in the 2025 report amounted to DKK 18,905.